Crispr Therapeutics Ag call shares owned by IMC-Chicago
Quarter-by-quarter ownership of Crispr Therapeutics Ag call shares owned by IMC-Chicago
from 13F filings
Historical chart of IMC-Chicago investment in Crispr Therapeutics Ag call
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics Ag call held by IMC-Chicago consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics Ag call by IMC-Chicago
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $6.3M | 92k | 68.16 |
| 2023-12-31 | $12M | 190k | 62.60 |
| 2023-09-30 | $7.1M | 157k | 45.39 |
| 2023-06-30 | $9.4M | 168k | 56.14 |
| 2023-03-31 | $8.4M | 187k | 45.23 |
| 2022-12-31 | $6.8M | 166k | 40.65 |
| 2022-09-30 | $12M | 181k | 65.35 |
| 2022-06-30 | $13M | 210k | 60.77 |
| 2022-03-31 | $7.7M | 122k | 62.77 |
| 2021-12-31 | $8.1M | 107k | 75.78 |
| 2021-06-30 | $16M | 99k | 161.89 |
| 2021-03-31 | $12M | 98k | 121.85 |
Top funds holding Crispr Therapeutics Ag call
View all funds holding Crispr Therapeutics Ag call